2025-04-14T18:55:19-05:00 2024-12-31 882730877 CHERRY BEKAERT ADVISORY LLC 2811 PONCE DE LEON BLVD STE 500 CORAL GABLES FL 33134 990 2024-01-01 200156638 NTM INFO & RESEARCH INC NTMI 3056676461 14411 S DIXIE HWY 205 PALMETTO BAY FL 33176 AMY LEITMAN PRESIDENT 3056676461 2025-03-27 1 0 GREGORY MARX P01677033 7866936300 2024 2025-03-06 01:10:19Z AMY LEITMAN 14411 S DIXIE HWY 205 PALMETTO BAY FL 33176 758500 0 X WWW.NTMINFO.COM X 2004 FL TO INCREASE EPIDEMIOLOGICAL, CLINICAL AND BASIC RESEARCH FOR NTM LUNG DISEASE, RAISE PHYSICIAN AWARENESS TO ENCOURAGE EARLIER DIAGNOSIS, AND PROVIDE MEANINGFUL NTM LUNG DISEASE PATIENT EDUCATION AND SUPPORT. 7 7 0 7 0 0 217466 565070 126734 189000 7603 4430 0 0 351803 758500 10010 9859 0 0 68231 64365 0 7202 64036 478343 827377 556584 908803 -204781 -150303 297304 147001 192 192 297112 146809 X SEE SCHEDULE O 0 0 730808 9859 189000 PROMOTE RESEARCH ON NONTUBERCULOUS MYCOBACTERIA (NTM) IN ORDER TO ENHANCE THE UNDERSTANDING AND BRING RECOGNITION OF NTM AS A TRUE DISEASE PATHOGEN, AND TO PROVIDE EDUCATION FOR PATIENTS, THEIR FAMILIES, AND HEALTHCARE PROVIDERS, SO THAT PATIENTS WILL BE DIAGNOSED EARLIER. 730808 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 6 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 7 7 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 0 0 0 AL AK AR CA CO CT FL GA HI IL KS KY MA ME MI MD MN MS NC ND NH NJ NV NY OH OK OR PA RI SC TN UT VA WA X X JAMES ZIMNY 3056676461 14411 S DIXIE HWY 205 PALMETTO BAY FL 33176 CONNIE KAZANJIAN DIRECTOR 10.00 X 0 0 0 PHILIP LEITMAN DIRECTOR 15.00 X 0 0 0 JAMES ZIMNY JR TREASURER 6.00 X X 0 0 0 DEBBIE BRESLAWSKY DIRECTOR 10.00 X 0 0 0 ELIZABETH GLAESER DIRECTOR 6.00 X 0 0 0 BRANDON MITCHELL BOARD CHAIR 6.00 X X 0 0 0 CANDACE LERMAN DIRECTOR 6.00 X 0 0 0 AMY LEITMAN PRESIDENT 50.00 X 64365 0 0 64365 0 0 0 0 0 0 0 565070 2845 565070 CONSULTING FEE INCOME 900099 189000 189000 189000 4430 4430 758500 189000 0 4430 X 9859 9859 64365 45056 12872 6437 6801 6801 7202 7202 165121 81949 59230 23942 34788 17394 17394 47419 34731 7753 4935 21327 6176 13828 1323 7200 7200 20345 20345 305186 305186 1435 1435 8409 2803 2803 2803 PATIENT ONLINE SERVICES 105696 105696 PROGRAM SUPPORT 101613 101613 LICENSING 2037 2037 908803 730808 113959 64036 169755 93655 125362 47294 2710 8405 5194 2187 3211 0 131 297304 147001 192 192 192 192 X 297112 146809 297112 146809 297304 147001 -150303 0 X 0 1 X 0 0 X 575693 582187 445759 217466 565070 2386175 575693 582187 445759 217466 565070 2386175 1170576 1215599 1545 47 1007 7325 4430 14354 2400529 340734 0.50640 0.48950 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8405 5194 3211 3211 X 758500 0 758500 0 758500 908803 0 908803 0 908803 PART X, LINE 2: NTMIR WAS ORGANIZED AS A NON-PROFIT ORGANIZATION AND HAS RECEIVED EXEMPTION UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. NTMIR DOES FILE A FORM 990 WITH THE INTERNAL REVENUE SERVICE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES IS PROVIDED FOR IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND AS SUCH DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. NTMIR IS SUBJECT TO ROUTINE AUDITS BY THE TAXING JURISDICTION. HOWEVER, THERE ARE CURRENTLY NO SUCH AUDITS IN PROGRESSS FOR ANY TAX PERIOD. 1 COPD FOUNDATION INC 3300 PONCE DE LEON BLVD MIAMI FL 33134 201048322 501(C)(3) 9300 0 RESEARCH 1 PART I, LINE 2: GRANTEES ARE REQUIRED TO SUBMIT PERIODIC REPORTS WHICH DETAIL ALL ASPECTS OF THE PROJECT AS OUTLINED IN THE SCOPE OF THEIR GRANT APPLICATION. THE FINAL REPORT AT COMPLETION OF PROJECT INCLUDES BUDGET DETAILING USE OF FUNDS. FORM 990, PART III, LINE 1 OUR MISSION IS TO SAVE AND IMPROVE LIVES THROUGH RESEARCH, EDUCATION, EARLY DETECTION AND IMPROVED TREATMENTS FOR PEOPLE WITH PULMONARY NONTUBERCULOUS MYCOBACTERIAL (NTM) DISEASE. BY SUPPORTING INNOVATIVE RESEARCH, WORKING WITH PATIENTS AND SUPPORT GROUPS, ENGAGING OUR CONSTITUENCIES TO INCREASE AWARENESS OF THE DISEASE, PROVIDING EDUCATION OPPORTUNITIES FOR PATIENTS AND HEALTHCARE, AND DEMONSTRATING LEADERSHIP AT ALL LEVELS, WE STRIVE TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS THAT WILL HELP PATIENTS AND BUILD A STRONGER NETWORK OF DOCTORS WHO ARE WELL-VERSED IN TREATING THIS DISEASE. FORM 990, PART VI, SECTION A, LINE 2 AMY LEITMAN - PRESIDENT AND PHILIP LEITMAN - DIRECTOR, ARE FATHER AND DAUGHTER. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS CIRCULATED AMONG MEMBERS OF THE ORGANIZATION'S FINANCE COMMITTEE FOR REVIEW, COMMENTS, AND APPROVAL PRIOR TO SUBMISSION FORM 990, PART VI, SECTION B, LINE 12C CURRENT POLICIES DO NOT PRECLUDE OFFICERS, DIRECTORS, TRUSTEES AND/OR EMPLOYEES FROM DOING BUSINESS WITH EACH OTHER. TO THE EXTENT THAT ANY SUCH BUSINESS DEALINGS MAY PRESENT A CONFLICT OF INTEREST, THEY ARE REQUIRED TO DISCLOSE SAME IN THE CONFLICT OF INTEREST POLICY STATEMENT, WHICH IS REQUIRED TO BE COMPLETED EACH YEAR AND TO FURTHER RECUSE THEMSELVES FROM VOTING ON ANY RELEVANT FOUNDATION BUSINESS MATTERS. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD CHAIR MAKES COMPENSATION RECOMMENDATIONS TO THE BOARD OF DIRECTORS, WHICH THEN APPROVES OR AMENDS THE RECOMMENDATION FOR APPROVAL. THE PRESIDENT OF THE ORGANIZATION MAKES RECOMMENDATIONS TO THE BOARD CHAIR ON COMPENSATION OF OTHER EMPLOYEES AND THE BOARD CHAIR HAS FINAL APPROVAL AFTER CONSULTATION WITH THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE LINKED ON THE ORGANIZATION'S WEBSITE AND ARE AVAILABE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING: PROGRAM SERVICE EXPENSES 3,125. MANAGEMENT AND GENERAL EXPENSES 1,500. FUNDRAISING EXPENSES 5,060. TOTAL EXPENSES 9,685. OPERATIONAL SUPPORT: PROGRAM SERVICE EXPENSES 78,824. MANAGEMENT AND GENERAL EXPENSES 57,730. FUNDRAISING EXPENSES 18,882. TOTAL EXPENSES 155,436.